FDA Panel Recommends Pfizer-BioNTech COVID-19 Vaccine for Kids 5 to 11

A federal advisory committee voted Oct. 26 to recommend that the Food and Drug Administration issue emergency authorization of the Pfizer-BioNTech pediatric COVID-19 vaccine for 5- to 11-year-olds.

No comments:

Post a Comment